Pathos AI raises $237 million at reported $3 billion valuation
Bristol Myers Squibb led Pathos AI’s Series E. The round was smaller than its 2025 financing, while its reported post-money valuation was higher.
biotechnology
-
-
NSF puts $90 million into three research centers for future technologies
Three five-year NSF centers will connect universities, labs and industry on turbulence, genome engineering and human-robot adaptation. Products are years away.
-
St. Louis Alzheimer’s diagnostics company lands first U.S. insurance coverage
C2N Diagnostics announced July 10 that its blood-based Alzheimer’s diagnostic received its first U.S. insurance coverage, a reimbursement milestone for the St. Louis-area company.